能動輸送

Active transport moves lipid-insoluble molecules against their concentration gradient using energy and specialized transporters. Unlike passive diffusion, active transport requires ATP or an electrochemical gradient to function. This process is selective, saturable, and susceptible to competitive inhibition, making it essential for moving substances cells cannot transport passively.

The Na+, K+-ATPase pump directly uses ATP to expel three sodium ions while moving two potassium ions into cells. This primary active transporter maintains cellular ion homeostasis. Digoxin inhibits this pump in cardiac cells, increasing intracellular sodium and enhancing calcium availability to improve heart muscle contractility in heart failure treatment.

P-glycoprotein is an ABC transporter that uses ATP to export various drugs out of enterocytes into the gastrointestinal lumen. This active transport mechanism significantly limits oral drug absorption by pumping drugs back into the GI tract. Understanding P-glycoprotein function is critical for predicting drug bioavailability and potential drug interactions.

In secondary active transport, symporters move both molecules in the same direction, while antiporters move one molecule inward and another outward. The Na+-Ca2+ exchange protein (SLC8) is an antiporter that uses inward sodium flow to drive outward calcium flow, maintaining low cytosolic calcium levels. Symporters like CNT1 and neurotransmitter transporters move sodium and their substrates together.

Secondary active transporters depend on electrochemical gradients established by primary active transporters like the Na+, K+-ATPase pump. The sodium gradient created by primary transport powers secondary transporters to move solutes across membranes. This coupled mechanism allows cells to transport diverse substrates including drugs, neurotransmitters, and nucleosides efficiently.

Neurotransmitter transporters like DAT, NET, and SERT are symporters that use the sodium gradient to move dopamine, norepinephrine, and serotonin into cells. These transporters harmonize sodium and neurotransmitter movement in the same direction. They have clinical significance as targets for CNS-active agents used in depression therapy and other neurological treatments.

Active transport mechanisms directly influence drug absorption, distribution, and elimination. Transporters like P-glycoprotein limit oral drug bioavailability by exporting drugs from enterocytes. Understanding active transport selectivity, saturation, and competitive inhibition is essential for predicting drug interactions, optimizing dosing strategies, and developing effective pharmaceutical therapies.